The National Multiple Sclerosis Society has announced funding for four new multiple sclerosis (MS) research projects under the third cycle of its Research Grant Programme. It has also launched the fourth cycle of the programme to further support MS research in the UAE.
The latest cycle saw strong participation from researchers across the UAE, with 36 letters of intent and 34 full applications submitted. After review, four projects were selected for funding, showing growing interest in MS research in the country.
The new grant cycle is themed “Advancing MS Innovation through Autoimmune Discovery.” It will support studies focused on improving understanding of MS, including immunobiology, genetic and environmental risk factors, new treatments, biomarker-based precision medicine, and better clinical care for patients.
According to Her Excellency Dr Fatima Al Kaabi, Vice Chair of the NMSS, the funded projects show the strong progress of the UAE’s research ecosystem, especially in artificial intelligence and precision medicine. She said local research will help improve treatment outcomes for people living with MS and also contribute to global knowledge.
Funded Research Projects
One study, led by Dr Bassem Yamout at Harley Street Medical Center, uses artificial intelligence (AI) to improve MRI accuracy. The goal is to better distinguish MS from neuromyelitis optica spectrum disorder, reduce misdiagnosis, and support earlier treatment decisions.
Another project by Dr Omer Alkhnbashi at Mohammed Bin Rashid University of Medicine and Health Sciences is developing an AI-based predictive tool. It combines clinical, imaging, and genetic data to help identify the best treatment options for MS patients in the UAE.
At New York University Abu Dhabi, Dr Youssef Idaghdour is leading the HEAL MS study. It examines how lifestyle changes such as nutrition, physical activity, and stress management can impact biological markers and improve wellbeing in MS patients.
Dr Nemat Ullah Khan from Khalifa University is studying a potential neuroprotective compound called Hi1a. Derived from Australian funnel-web spider venom, it is being tested using brain organoids to explore nerve protection and myelin repair.
Programme Funding and Future Cycle
Since its launch in June 2023, the NMSS Research Grants Programme has allocated nearly AED 11 million to MS-related research. These studies focus on new treatments, disease understanding, prevalence in the UAE, and genetic research.
For the fourth cycle, researchers must submit letters of intent between 1 June and 5 July 2026, followed by full proposals by 23 August 2026. Final funding decisions will be announced in December 2026.
